Abstract-In certain cardiovascular disorders, such as congestive heart failure and ischemic heart disease, several endogenous regulators, including norepinephrine (NE) and endothelin-1 (ET-1), are released from various types of cell. Because plasma levels of these regulators are elevated, it seems likely that cardiac contraction might be regulated by crosstalk among these endogenous regulators. We studied the regulation of cardiac contractile function by crosstalk between ET-1 and NE and its relationship to Ca 2ϩ signaling in canine ventricular myocardium. ET-1 alone did not affect the contractile function. However, in the presence of NE at subthreshold concentrations (0.1 to 1 nmol/L), ET-1 had a positive inotropic effect (PIE). In the presence of NE at higher concentrations (100 to 1000 nmol/L), ET-1 had a negative inotropic effect. ET-1 had a biphasic inotropic effect in the presence of NE at an intermediate concentration (10 nmol/L). The PIE of ET-1 was associated with an increase in myofilament sensitivity to Ca 2ϩ ions and a small increase in Ca 2ϩ transients, which required the simultaneous activation of protein kinase A (PKA) and PKC. ET-1 elicited translocation of PKC⑀ from cytosolic to membranous fraction, which was inhibited by the PKC inhibitor GF 109203X. Whereas the Na ϩ -H ϩ exchange inhibitor Hoe 642 suppressed partially the PIE of ET-1, detectable alteration of pH i did not occur during application of ET-1 and NE. The negative inotropic effect of ET-1 was associated with a pronounced decrease in Ca 2ϩ transients, which was mediated by pertussis toxin-sensitive G proteins, activation of protein kinase G, and phosphatases. When the inhibitory pathway was suppressed, ET-1 had a PIE even in the absence of NE. Our results indicate that the myocardial contractility is regulated either positively or negatively by crosstalk between ET-1 and NE through different signaling pathways whose activation depends on the concentration of NE in the dog. Key Words: endothelin-1 Ⅲ norepinephrine Ⅲ myocardial contractility Ⅲ Ca 2ϩ transients Ⅲ protein kinase C D uring the course of cardiovascular disorders, such as congestive heart failure and ischemic heart disease, plasma levels of both endothelin-1 (ET-1) and norepinephrine (NE) tend to increase. [1] [2] [3] [4] The signal transduction processes that are triggered by the activation of receptors for these endogenous agonists are different, and, thus, it seems likely that crosstalk between ET-1 and NE might play a critical role in the regulation of cardiac function, determining hemodynamic responses to antagonists of ␤-adrenoceptors or endothelin receptors under various pathophysiological conditions. The available evidence implies that these endogenous regulators are engaged in crosstalk at different levels of their respective signaling pathways. For example, the positive feedback mechanism seems to exist at the level of the synthesis of NE by which ET-1 increases the plasma concentration of NE, 5 whereas NE facilitates the expression of mRNA that encodes the prepro-ET-1 6 and the production of ET-1. 7 ET-1 has a positive inotropic effect (PIE) in ventricular myocardium of most mammals, but it has no inotropic effect on canine ventricular myocardium. 8, 9 By contrast, ET-1 has a negative inotropic effect (NIE) in the presence of catecholamines and antagonizes the ␤-adrenoceptor-mediated facilitatory regulation of contractile function in several mammalian species, including the dog. 10 -14 Regulation of myocardial contractility induced by crosstalk between ET-1 and NE has not been studied in detail. It has been reported that the acceleration of the hydrolysis of phosphoinositide and the subsequent generation of inositol 1,4,5-trisphosphate and 1,2-diacylglycerol might be responsible for the PIE of ET-1 in certain species, 8 but the subcellular mechanism involved in the NIE of ET-1 has not been fully elucidated. We designed Original
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uring the course of cardiovascular disorders, such as congestive heart failure and ischemic heart disease, plasma levels of both endothelin-1 (ET-1) and norepinephrine (NE) tend to increase. [1] [2] [3] [4] The signal transduction processes that are triggered by the activation of receptors for these endogenous agonists are different, and, thus, it seems likely that crosstalk between ET-1 and NE might play a critical role in the regulation of cardiac function, determining hemodynamic responses to antagonists of ␤-adrenoceptors or endothelin receptors under various pathophysiological conditions. The available evidence implies that these endogenous regulators are engaged in crosstalk at different levels of their respective signaling pathways. For example, the positive feedback mechanism seems to exist at the level of the synthesis of NE by which ET-1 increases the plasma concentration of NE, 5 whereas NE facilitates the expression of mRNA that encodes the prepro-ET-1 6 and the production of ET-1. 7 ET-1 has a positive inotropic effect (PIE) in ventricular myocardium of most mammals, but it has no inotropic effect on canine ventricular myocardium. 8, 9 By contrast, ET-1 has a negative inotropic effect (NIE) in the presence of catecholamines and antagonizes the ␤-adrenoceptor-mediated facilitatory regulation of contractile function in several mammalian species, including the dog. 10 -14 Regulation of myocardial contractility induced by crosstalk between ET-1 and NE has not been studied in detail. It has been reported that the acceleration of the hydrolysis of phosphoinositide and the subsequent generation of inositol 1,4,5-trisphosphate and 1,2-diacylglycerol might be responsible for the PIE of ET-1 in certain species, 8 but the subcellular mechanism involved in the NIE of ET-1 has not been fully elucidated. We designed the present study in an attempt to characterize the contractile regulation induced by crosstalk between ET-1 and NE over a wide range of concentration and its relationship to the regulation of Ca 2ϩ signaling in canine ventricular myocardium. We examined subcellular mechanisms responsible for such regulation using selective inhibitors of protein kinases and other types of enzyme. ET-1 had a PIE and NIE, depending on the concentration of NE present before administration of ET-1. The effects were mediated by an increase in the myofilament sensitivity to Ca 2ϩ or a decrease in Ca 2ϩ transients, which were induced by activation of different signaling pathways in dog ventricular myocardium. Preliminary accounts of this study have been published elsewhere. 13, [15] [16] [17] [18] 
Materials and Methods
All manipulations of animals were performed in accordance with the Guide for Animal Experimentation, Yamagata University School of Medicine, and Japanese Governmental Law (No. 105). Approval for all experiments with animals was obtained from the Committee for Animal Experimentation, Yamagata University School of Medicine, before the experiments, and the study was also carried out in accordance with the Helsinki Declaration. Mongrel dogs (7 to 10 kg) of both sexes were used in these experiments, which were performed as described previously. 11, 14, 19 
Isolation and Treatment of Canine Ventricular Trabeculae
The heart was excised, beating was ceased in cold Tyrode solution (Ϸ7°C) bubbled with 95% CO 2 and 5% O 2 , and 2 to 4 thin trabeculae carneae of the right ventricular wall (Ͻ1 mm in diameter) were isolated and mounted in 20-mL organ baths that contained KrebsHenseleit solution. 8, 11 The ventricular trabeculae were stimulated electrically with square-wave pulses of 5-ms duration and a voltage that was 20% above the threshold (Ϸ0.4 V) at a frequency of 0.5 Hz.
The average length of muscle preparations was 7.39Ϯ0.52 mm, and the average cross-sectional area was 1.43Ϯ0.19 mm 2 (nϭ165, from a total of 73 dogs).
ET-1 was administered at a single concentration to each muscle preparation. Selective inhibitors were administered 20 to 30 minutes before the addition of ET-1 and were present in the organ bath throughout respective experiments. Pertussis toxin (PTX) at 0.5 g/mL was allowed to act for 10 hours before experiments were started.
Preparation and Analysis of Canine Ventricular Myocytes
A portion of the free wall of the left ventricle that is supplied via a branch of the left anterior descending artery was excised. The artery was cannulated and perfused with Tyrode's solution that contained 1.0 mg/mL collagenase and 0.1 mg/mL protease via a recirculating system for 15 to 25 minutes at room temperature (24°C). Then the muscle was perfused with Tyrode's solution that contained 0.2 mmol/L CaCl 2 and cut into small pieces Ϸ3ϫ3 mm 2 with a 
Subcellular Localization of Protein Kinase C Isoforms
The subcellular fractionation procedures, antibodies, and Western blotting techniques are described in the online data supplement.
Statistical Analysis
Experimental values are presented as meanϮSE. Significant differences between mean values were estimated by a repeated-measures ANOVA or by Student's t test with analytic software STATVIEW J-4.5 (Abacus Concepts). PϽ0.05 was judged to indicate a significant difference.
Results

Influence of NE on the Inotropic Effects of ET-1
Endothelin-1 at 1 to 100 nmol/L did not, by itself, affect the peak twitch force. However, in the presence of NE at the subthreshold concentration of 1 nmol/L, ET-1 at 10 and 100 nmol/L had a definite PIE in association with negative lusitropic and clinotropic (the effect on time to peak tension) effects (data not shown), and these effects of ET-1 were concentration-dependent ( Figures 1A and 1B) . The EC 50 value for ET-1 in the presence of NE at 1 nmol/L was 34.0Ϯ5.90 nmol/L (determined in 37 preparations from 14 dogs, including data presented in Reference 15).
NE had a concentration-dependent PIE at 10, 100, and 1000 nmol/L equivalent to 11.5Ϯ4.1% (nϭ5), 80.4Ϯ8.4% (nϭ5), and 248.3Ϯ27.4% (nϭ8) of the basal force, respectively, and the threshold concentration and EC 50 value were 3 nmol/L and 0.87Ϯ0.09 mol/L, respectively. When the NE concentration before the administration of ET-1 was increased, the PIE of ET-1 was converted to a NIE, depending on the concentration of NE. In the presence of 10 nmol/L NE, 10 nmol/L ET-1 induced a biphasic inotropic response (ie, a transient NIE followed by a long-lasting PIE); in the presence of NE at higher concentrations (Ն100 nmol/L), ET-1 had a definite NIE ( Figure 1C ). In the presence of NE at 1000 nmol/L, the NIE of ET-1 was markedly reduced, and ET-1 did not have any inotropic effect in the presence of 10 mol/L NE ( Figure 1D ). Figure 2C ), an indication that the increase in cell shortening induced by ET-1 was attributable, at least in part, to an increase in the myofilament sensitivity to Ca 2ϩ . NE at 100 nmol/L induced a pronounced increase in the maximum cell shortening together with a remarkable increase in Ca 2ϩ transients. ET-1 markedly decreased the NE-induced increase in cell shortening and Ca 2ϩ transients ( Figures 3A  and 3B ). The NE-induced increases in cell shortening and Ca 2ϩ transients were inhibited by ET-1 to an essentially similar extent ( Figure 3C ), and the relationship between the amplitudes of cell shortening and Ca 2ϩ transients that was observed with NE alone was unaffected by ET-1 (data not shown).
Regulation of Ca
In the presence of NE at an intermediate concentration of 10 nmol/L, ET-1 had a biphasic effect, inducing a transient decrease in cell shortening that was associated with a decrease in Ca 2ϩ transients, followed by a long-lasting increase in cell shortening that was associated with a statistically insignificant alteration of Ca 2ϩ transients ( Figures 4A and  4B ). Summary of these data are presented in Figure 4C . Our findings indicate that, in the presence of 10 nmol/L NE, the inotropic response to ET-1 involves a combination of facilitatory and inhibitory effects.
Similar results were obtained in aequorin-loaded canine right ventricular trabeculae (see the online data supplement). Figure 5 shows the effects of selective inhibitors of cAMPmediated and protein kinase C-mediated (PKC-mediated) pathways on the PIE of ET-1 in the presence of a subthreshold concentration of 1 nmol/L NE. The PIE of ET-1 was abolished by treatment of trabeculae with timolol (1 mol/L), which blocks ␤-adrenoceptors, and with H-89 (1 mol/L), an inhibitor of protein kinase A (PKA; Figure 5A ). These inhibitors, at the concentrations used, did not affect the PIE induced by an elevation of [Ca 2ϩ ] o (data not shown). The inhibitors of PKC, staurosporine (10 nmol/L) and H-7 (10 mol/L), and an inhibitor of phospholipase C (PLC), neomycin (10 mol/L), abolished the PIE of ET-1 in the presence of 1 nmol/L NE ( Figure 5A ). These selective inhibitors, at the concentrations used, did not affect the PIE of NE that was induced by activation of ␤-adrenoceptors (data not shown). Carbachol (0.1 mol/L), which selectively inhibits the cAMP-mediated PIE, 20 also reversed the PIE of ET-1 ( Figure 5B ). These results indicate that the PIE of ET-1 in the presence of NE requires the simultaneous activation of PKA and PKC signaling pathways. Figure 6B ). These selective inhibitors had no effects on the basal force and on the PIE of NE mediated by ␤-adrenoceptors (data not shown).
Signal Transduction Pathway for the ET-1-Induced PIE
Unmasking of the PIE of ET-1 by Suppression of Inhibitory Pathways
After the pretreatment of trabeculae with PTX ( Figure 7A ) and the treatment with KT5823 ( Figure 7B ) or with cantharidin ( Figure 7C ), ET-1 (10 nmol/L) had a PIE even in the absence of NE.
Influence of GF 109203X and Hoe 642 on PKC⑀ Translocation
We had examined the subcellular distribution of 4 major PKC isoforms (␣, ␤, ␦, and ⑀) by immunoblotting with the use of isoform-specific antibodies. We found that the dog right ventricle expressed ␣ and ⑀ isoforms, whereas no significant immunoreactivity was detected for ␤ and ␦. Because the subcellular localization of the PKC␣ isoform did not change in response to pharmacological stimuli, we reported data for the PKC⑀ isoform in the present study.
Representative immunoblots of the PKC⑀ isoform are shown in Figure 8A . The membrane-associated immunoreactivity was markedly increased in response to phorbol dibutyrate and ET-1ϩNE. The translocation of PKC⑀ to the membranous fraction by ET-1ϩNE was completely blocked by GF 109203X (a selective PKC inhibitor, 1 mol/L) but not by Hoe 642 (a Na ϩ /H ϩ inhibitor, 1 mol/L) ( Figure 8B ). Under the same experimental condition, Hoe 642 suppressed significantly (PϽ0.05) the PIE induced by combination of ET-1 with NE by Ϸ40% (control, 151Ϯ5.6%; Hoe 642, 132Ϯ4.8%; nϭ4 each).
Discussion
In the present study, we demonstrated that the extent and quality of the inotropic effects of ET-1 in canine ventricular myocardium are determined by the concentration of simultaneously applied NE, with the functional outcome of coupling subsequent to stimulation of ET receptors being dependent, apparently, on the extent of ␤-stimulation by NE. The regulation of contraction induced by ET-1 involves activation of PKC, of a G s protein-coupled cAMP/PKA pathway, and of a PTX-sensitive G i protein-coupled cGMP/PKG/PP pathway.
By itself, ET-1 did not induce any inotropic response, but it had a definite PIE in the presence of NE at 0.1 to 1 nmol/L, which did not significantly affect the basal force. The PIE of ET-1 was converted to a NIE when the concentration of NE was increased. ET-1 had a prominent NIE in the presence of NE at 100 nmol/L and higher, and these observations are essentially consistent with previous reports that ET-1 attenuated the PIE and positive chronotropic effect of ␤-stimulation in the dog, 11 rat, 21 and guinea pig. 22 Our results indicate that in the presence of NE, positive and negative inotropic responses compete with one another and that, in the presence of NE at high concentrations, the PIE of ET-1 is completely replaced by a NIE. This crosstalk between ET-1 and NE might contribute significantly to the variable inotropic responses to ET-1; in previous studies, ET-1 had no effect, 8, 9, 23 a PIE, 4, 8 and a NIE, 24 -26 including a timedependent component to these phenomena. 27 
Differential Regulation of Ca 2؉ Signaling by ET-1
The PIE of ET-1 in the presence of a threshold concentration of NE was associated with a small increase in Ca 2ϩ transients. 
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This increase was significantly smaller than that induced by an increase in [Ca 2ϩ ] o that elicited a PIE equivalent to that of ET-1 (Figure 2 ). These observations imply that the PIE of ET-1 is associated definitively with an increase in the myofilament sensitivity to Ca 2ϩ , being consistent with previous findings with ET-1 in other species. 19,28 -30 Because ET-1 did not have a PIE in the presence of inotropic interventions, such as dihydroouabain or an increase in [Ca 2ϩ ] o , 13 ET-1 might require a weak ␤-stimulation for induction of its PIE. This synergistic action of ET-1 and NE indicates that there is a critical difference in the regulation between the dog and other mammals. 8,19,29 -31 In mice, ␤-stimulation and ET-1 regulate cardiac contractility in opposite directions in part through phosphorylation of troponin I on distinct sites, 32 indicating that the phosphorylation of contractile proteins plays a crucial role in the regulation, the role of which could not be determined in the present study.
In contrast to the PIE, the NIE of ET-1 was accompanied by a pronounced decrease in Ca 2ϩ transients (Figure 3) , which may play a key role in the NIE of ET-1. We investigated in dog ventricular myocytes that ET-1 inhibited significantly the increase in L-type Ca 2ϩ current (I Ca ) induced by isoproterenol. 14 Because the inhibitory action of ET-1 on the isoproterenol-induced increase in I Ca was suppressed by the treatment with PTX in rabbit myocytes, the inhibition of the cAMP-mediated increase in I Ca via the PTX-sensitive inhibitory pathway activated by ET-1 might contribute, to some extent, to the ET-1-induced decrease in Ca 2ϩ transients. Involvement of effects on other processes, such as PKA and SR Ca 2ϩ release, however, is not excluded. Present observations with indo-1-loaded myocytes are consistent with findings obtained with aequorin-loaded dog ventricular trabeculae (online data supplement). 18 
Subcellular Mechanisms for the PIE of ET-1
Neomycin, staurosporine, and H-7, at a concentration that did not affect the PIE of NE mediated by ␤-adrenoceptors, abolished the PIE of ET-1. Furthermore, timolol and H-89 completely suppressed the PIE of ET-1 ( Figure 5A ), whereas carbachol reversed the PIE of ET-1 ( Figure 5B ). These observations together imply that the ET-1-induced PIE and increase in the myofilament sensitivity to Ca 2ϩ require the simultaneous activation of PKC and PKA.
Although the Na ϩ -H ϩ exchange inhibitor Hoe 642 inhibited partially the PIE of ET-1, we could not detect an appreciable alteration of pH i in single myocytes loaded with the fluorescent pH i probe SNARF-1 (online data supplement).
We found recently that the Ca 2ϩ -sensitizing actions of OR-1896 and levosimendan were abolished by carbachol, [33] [34] [35] an indication that a Ca 2ϩ -sensitizing mechanism might exist that requires accumulation of cAMP. Although myosin-binding protein C, which is phosphorylated via a cAMP/PKA signaling pathway, might be a candidate for the source of increased sensitivity to Ca 2ϩ , 36 the target proteins responsible for such a cAMP-mediated increase in Ca 2ϩ -sensitivity remain to be identified. The selectivity of staurosporine and H-7 was checked by comparing the concentration-dependent effect of these agents on the ␣-and ␤-mediated PIE, 37, 38 which is discussed in detail in online data supplement.
Treatment with cantharidin and with KT5823 and pretreatment with PTX unmasked the PIE of ET-1 even in the absence of NE. These findings indicate that the signaling process that leads to activation of G i -proteins, PKG, and phosphatases might be highly effective even in the baseline state, counteracting the G q -/G s -mediated PIE via suppression of cAMP-mediated signaling and leading to the absence of a PIE of ET-1; ie, ET-1 stimulates both G q and G i proteins, accounting for the activation of facilitative and inhibitory ( Figure 7 ).
Subcellular Mechanisms for the NIE of ET-1
The selective inhibitors that abolished the PIE enhanced the NIE of ET-1 ( Figure 6 ), an indication that the NIE of ET-1 is mediated by signaling processes that are different from those involved in the induction of the PIE of ET-1. Because the NIE of ET-1 was almost completely inhibited by pretreatment with PTX, the accumulation of cAMP induced by ␤-stimulation might be suppressed by the G i -mediated deactivation of adenylyl cyclase. However, this scenario is unlikely, because the NIE of ET-1 is not accompanied by a significant reduction in the accumulation of cAMP that is mediated by ␤-stimulation. 10, 11, 39 Although ␤ 2 -adrenoceptors that are coupled to G i proteins are activated by NE 40 and could come into play in the NIE of ET-1 in the presence of high concentrations of NE, the findings with ET-1 in the presence of various ␤-adrenoceptor agonists, including the ␤ 2 -selective agonist zinterol, exclude the essential role of ␤ 2 -subtype in the NIE of ET-1 41 (online data supplement).
Both LY83583, an inhibitor of GC, and KT5823, an inhibitor of PKG, suppressed the NIE of ET-1, an indication that G i -coupled cGMP/PKG signaling might be responsible for the inhibitory action of ET-1, whereas nitric oxide is not involved in such regulation. 10, 11 It has been reported that G i -coupled receptors, such as muscarinic M 2 42 and adenosine A 1 receptors, 43 counteract the effect of activation of PKA, in part via the activation of PP: the muscarinic agonists acetylcholine and carbachol inhibit protein phosphatase inhibitor-1 (PPI-1) through G i -mediated stimulation of the PP activity with resultant dephosphorylation of a variety of functional proteins that are phosphorylated by PKA. 44 -47 The muscarinic inhibition could occur without a concomitant decrease in the cAMP content or in the PKA activity. 45, 46 Our observation that an inhibitor of PP, cantharidin, abolished the NIE of ET-1 is consistent with the results of previous investigations described above. In this context, it is noteworthy that the NIE of ET-1 is more susceptible to cantharidin than the NIE of carbachol and the PIE of NE mediated by ␤-adrenoceptors, 48 an indication that the differential effect of cantharidin on various signaling processes is exerted in dog ventricular myocardium.
In summary, ET-1 has a positive effect, biphasic effect, or NIE, depending on the extent of ␤-stimulation in canine ventricular myocardium. The PIE of ET-1 might be attributable to activation of the PLC/PKC pathway, requiring simultaneous activation of the process that is mediated by cAMP. By contrast, the NIE of ET-1 can be ascribed to activation of phosphatases via G i -coupled cGMP/PKG signaling. The PIE was associated with an increase in the myofilament sensitivity to Ca 2ϩ , whereas the NIE was attributable to a decrease in Ca 2ϩ transients. The crosstalk between ET-1 and NE might play a crucial role in the regulation of myocardial contractility under pathophysiological conditions that are associated with elevated plasma levels of endogenous regulators.
